Susanne Knorr, Senior Consultant Neurologist and Researcher Würzburg University Hospital. Photo by Stephan Röhl Our congratulations to Dr. Susanne Knorr, department of Neurology, University Hospital of Würzburg, Germany and the David Marsden Award 2022 winner for her paper: “The evolution of dystonia-like movements in TOR1A rats after transient nerve injury is accompanied by dopaminergic dysregulation and…
Prof. Tom Warner, Queen Square London: About the Research of Dr. Susanne Knorr, the David Marsden Award Winner 2022
The changes in the brain that lead to dystonic movements have been the subject of extensive investigation, particularly for the genetic forms. DYT1 dystonia is the commonest genetic cause of childhood onset dystonia and various studies in cell, animal and human studies suggest it is due to a problem with circuits controlling movement, focused on…
Dr Susanne Knorr Receives the David Marsden Award 2022
Our congratulations to Dr. Susanne Knorr, department of Neurology, University Hospital of Würzburg, Germany and the David Marsden Award 2022 for her paper: “The evolution of dystonia-like movements in TOR1A rats after transient nerve injury is accompanied by dopaminergic dysregulation and abnormal oscillatory activity of a central motor network.” Dr. Knorr was presented with the…
Dystonia Research Update
We are delighted to present this new page in our newsletter. Here we will share the most recent publications in the field of dystonia research together with a summary in lay language. Ledda C, Artusi CA, Tribolo A et al. Time to onset and duration of botulinum toxin efficacy in movement disorders. J Neurol. 2022…
DBS study in Germany is still Recruiting Patients suffering from Cervical Dystonia
A randomized, sham-controlled trial of pallidal neurostimulation versus botulinum toxin treatment for cervical dystonia (StimTox-CD) Deep brain stimulation (DBS) of the internal globus pallidus is highly effective for various forms of primary dystonia, but is currently considered a last resort therapy for severe and medication-refractory segmental or generalized dystonia according to treatment guideline. The first-line treatment…
